Outcomes of comorbid mental health disorders in cardiovascular surgery Authors: Grace M Soltesz, Jose L Diz Ferre, Guangjin Zhou, Siran M Koroukian, Krish C Dewan Published: 2026 ABSTRACT AbstractBackgroundMental illness is recognized by the Centers for Disease Control and Prevention as a global public health problem. Traditional cardiac surgical risk stratification tools typically do not include any assessment for mental illness. This study sought to examine the impact of pre-existing mental health disorders (MHDs) (including psychotic, mood, anxiety, behavioral, and personality disorders) on in-hospital cardiovascular surgery outcomes.MethodsThis study used the 2016–2018 Nationwide Readmissions Database (NRD). It identified patients undergoing cardiovascular surgery and flagged those with and without MHDs using the relevant procedure and diagnosis codes. A propensity score matching (PSM) approach was used to balance covariates between patients with and without MHDs to evaluate the association between MHDs and each of the complications, in-hospital mortality, 30- and 90-day readmissions. Subsequently, multivariable logistic regression was conducted to evaluate the independent association between MHDs and the study outcomes, after adjusting for covariates.ResultsOf the 844,830 discharges who underwent cardiovascular surgery, 165,597 (20%) had MHDs. Among propensity score-matched pairs, in-hospital mortality was lower in patients with MHDs (2.3% vs. 3.2%, P<0.001), possibly because those undergoing surgery are among the healthier and/or least disadvantaged individuals among those with MHDs. However, they had a longer mean length of stay (LOS; 12 vs. 11 days, P<0.001). MHDs were also associated with higher odds of complications [adjusted odds ratio (aOR): 1.16, 95% confidence interval (CI): 1.14–1.19], and higher odds of 30- and 90-day readmission (aOR: 1.17, 95% CI: 1.14–1.21; and aOR: 1.18, 95% CI: 1.14–1.21, respectively).ConclusionsSurgeons may consider optimizing psychiatric status and involving mental health professionals to improve outcomes in this vulnerable population.Keywords: Cardiovascular surgery, mental health disorders (MHDs), nationwide outcomes Highlight box Key findings • In-hospital mortality was lower in patients with mental health disorders (MHDs) (2.3% vs. 3.2%, P<0.001). • Overall incidence of complications was higher (42.1% vs. 39.1%, P<0.001). • Patients with MHDs had increased odds of readmission at 30 and 90 days [odds ratio (OR): 1.17, 95% confidence interval (CI): 1.14–1.21 and OR: 1.18, 95% CI: 1.14–1.21, respectively]. What is known and what is new? • The Center for Disease Control and Prevention has recognized mental health as a global public health issue, given its substantial societal impact. • Although in-hospital mortality was lower in patients with MHDs than without, patients with MHDs had higher in-hospital complications and readmissions. What is the implication, and what should change now? • Patients with MHDs have increased complications and odds of readmission. • Surgeons may consider optimizing mental health status and involving mental health professionals to improve outcomes in this population. Introduction Mental health disorders (MHDs) pose a significant public health concern, estimated to affect one in five adults in the U.S. (59.3 million in 2022) (1). The Centers for Disease Control and Prevention has recognized mental health as a global public health issue, given its high prevalence and substantial societal impact (2). While the influence of MHDs on various surgical outcomes has been studied (3), their impact specifically on cardiovascular surgery remains underexplored. Cardiovascular surgeries are complex and high-risk procedures that require careful patient selection and risk stratification. Traditional cardiac surgical risk stratification tools, such as the Society of Thoracic Surgeons and the EuroSCORE scores, do not typically include any mental illness domains (4-6). However, growing evidence suggests that mental health status significantly influences surgical outcomes, including postoperative complications, and readmission (7-9). Accordingly, the present study aims to assess the impact of MHDs on patients undergoing cardiovascular surgery, specifically the association between MHDs (including psychotic, mood, anxiety, behavioral, and personality disorders) and in-hospital cardiovascular surgery outcomes. The working hypothesis is that patients with MHDs are more likely than those without to experience adverse outcomes. We present this article in accordance with the STROBE reporting checklist (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2025-aw-2208/rc). Methods This study was deemed not human subjects research by the Case Western Reserve University Institutional Review Board (STUDY20201146) and hence was exempt from review. Data source and study population This retrospective observational study utilized the U.S. Nationwide Readmissions Database (NRD), an administrative database sponsored by the Agency for Healthcare Research and Quality (AHRQ) for the Healthcare Cost and Utilization Project (HCUP), designed to support various types of analyses of national readmissions for all patients regardless of age or payer type (10). This database contains data from approximately 16.5 million discharges in the United States and estimates roughly 32.9 million discharges when weighted. It provides national discharge-level data carrying International Classification of Diseases, 10th revision, Clinical Modifications (ICD-10-CM) diagnosis and procedure codes. We used ICD-10-CM F diagnosis codes (20–25, 28–34, 38–42, 44, 45, 48, 50–55, 59–66, 68 and 69) to identify patients with pre-existing MHDs, including psychotic, mood, anxiety, behavioral, and personality disorders. We obtained data from the 2016–2018 NRD for all patients undergoing isolated coronary artery bypass surgery, valve surgery, aortic surgery, or a combination thereof [Clinical Classifications Software (CSS) procedure codes 44, 43, and 52, respectively]. From the 860,128 admissions with cardiovascular procedures, we applied the following exclusion criteria: left ventricular assisting device, heart transplant, age <18 or >100 years, pregnancy, and missing data in the DaysToEvent, length of stay (LOS), or Died variables (Figure S1). Our study population included 844,830 patients, of whom 165,597 (19.6%) had MHDs. Variables and outcomes Demographic variables included age (grouped in the following categories: 18–44, 45–54, 55–64, 65–74, 75–84, and 85+), and sex (male and female). Insurance status (Medicaid, Medicare, private, uninsured and others), median household income level (1st to 4th quartile), and hospital characteristics were also accounted for in the study. A hospital was considered as teaching if it has one or more residency programs approved by the Accreditation Council for Graduate Medical Education (ACGME), is a member of the Council of Teaching Hospitals (COTH), or has a ratio of full-time equivalent interns and residents to beds of 0.25 or higher (11). Bed size was categorized by the AHRQ as small, medium, and large, and it assesses the number of short-term acute care beds set up and staffed in a hospital. Bed size definition varies according to the country’s region (Northeast, Midwest, Southern, or Western), and the hospital’s location and teaching status (i.e., Rural, Urban non-teaching, or Urban teaching) (12). Elective admission status is a variable in the NRD to indicate whether the admission to the hospital was elective (vs. non-elective). Comorbidities, obtained from the NRD, were defined based on the Elixhauser Comorbidity Index, a validated tool for measuring comorbidity burden among patients included in administrative databases (11). Outcomes included complications, in-hospital mortality, LOS and readmissions at 30 and 90 days. Complications included stroke (ischemic and hemorrhagic), bleeding, blood transfusion, renal failure, pneumonia, surgical site infection, sepsis, post-procedural or postoperative respiratory complications, pulmonary embolism, deep venous thrombosis, cardiac complications, and gastrointestinal complications. ICD-10-CM codes used for these conditions are provided in Table S1. Readmission was defined as the first admission following the index admission for surgery. Readmission analyses were stratified into two separate periods: 30 and 90 days. Patients undergoing cardiac surgery were identified from January to November of each calendar year (n=145,615 and 139,494 in MHD and non-MHD cohorts) to ensure 30-day follow-up. Similarly, patients in the 90-day analyses were identified from January to September (n=118,878 and 114,473 in MHD and non-MHD cohorts) to ensure 90-day follow-up. Patients who died during the index admission (or the first admission in a given calendar year during which the patient underwent cardiovascular surgery) were excluded because deceased individuals cannot be readmitted. The above numbers reflect cohorts after propensity score matching (PSM). Statistical analysis All analyses were conducted using the SAS System for Unix, version 9.4 (SAS Institute, Inc., Cary, NC, USA). Discharge weights were used to create national estimates. Categorical variables were summarized as frequencies and percentages. Chi-square and Student’s test were used to compare categorical and continuous variables between patients with and without MHDs. The association between MHDs and surgical outcomes was evaluated using a propensity score-matching approach. Propensity-matched analysis was conducted to adjust for covariates between patients with and without MHDs and to eliminate the effects of confounding factors on outcomes. A 1:1 greedy matching algorithm with a caliper of 0.1 times the standard deviation of the linear propensity score was used. Covariates balance before and after matching were assessed using standardized differences between those with and without MHD (Figure S2). The following variables were selected for use in the PSM model: procedure type, age, sex, elective (vs. non-elective) admission, household income quartile, insurance, blood loss anemia, heart failure, chronic pulmonary disease, and diabetes (complicated and uncomplicated), hypertension, liver disease, pulmonary circulation disease, renal failure and weight loss. Logistic regression analysis was conducted before and after PSM to evaluate the independent association between MHDs and outcomes of interest, adjusting for potential confounders, including age, sex, household income quartile, insurance, hospital urban-rural designation, teaching status, bed size, ownership and Elixhauser risk score. These variables were included to account for socioeconomic vulnerabilities and hospital-level factors that may be associated with both MHD status and surgical outcomes. The full models before and after PSM are presented in Tables S2-S5. Lastly, we note that given the large sample size, we relied less on P values and more on the meaningfulness of the observed differences when interpreting the findings. Results Patient characteristics MHDs were relatively common pre-operative comorbidities among patients who underwent cardiac surgery, as 165,597 (19.6%) were identified with mood disorder, schizophrenia, anxiety disorder, behavioral syndrome, or personality disorder. Table 1 compares the prevalence of psychiatric conditions comprising MHDs among patients who underwent cardiovascular procedures and those from the NRD who did not. The results showed a higher prevalence of anxiety and behavioral disorders among those who underwent cardiovascular surgery compared with those who did not (68.0% vs. 57.8%), but a lower prevalence of mood disorders and psychotic disorders (56.5% vs. 73.8%), attesting to the fact that individuals with more serious mental illness diagnoses have lower representation in the cardiovascular surgery group than in the general population. Table 1Prevalence of mental health disorders among patients who underwent cardiovascular surgery and those who did notMental health disorderSurgery, n (%)No surgery, n (%)Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders4,034 (2.4)1,572,535 (9.3)Mood (affective) disorders89,546 (54.1)10,956,981 (64.5)Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders112,649 (68.0)9,827,825 (57.8)Behavioral syndromes associated with physiological disturbances and physical factors720 (0.4)143,041 (0.8)Disorders of adult personality and behavior763 (0.5)479,043 (2.8) Prevalence of mental health disorders among patients who underwent cardiovascular surgery and those who did not Hereafter, all results pertain to patients who underwent cardiovascular surgery and compare outcomes between those with and without MHDs. Baseline demographics and characteristics are presented in Table 2. The MHD cohort had a larger representation of patients younger than 65 years of age (49.5%) than the non-MHD cohort (41.1%), fewer men (58.3% vs. 74.1%), and a larger percentage of Medicaid-insured patients (10.3% vs. 7.0%). Additionally, more patients with MHD than without were admitted for elective surgery (50.4% vs. 45.3%), and valve-only procedures were somewhat more common in the MHD than in the non-MHD group (22.2% vs. 19.8%). We observed no marked differences in hospital characteristics between the two groups (Table 3). Table 2Preoperative patient characteristics and operative details stratified by MHD before propensity score matchingCharacteristicMHD (N=165,597)No MHD (N=679,233)P valueDemographics Sex, n (%)<0.001 Male96,539 (58.3)503,319 (74.1) Female69,057 (41.7)175,914 (25.9) Age, n (%)<0.001 18–44 years11,463 (6.9)28,909 (4.3) 45–54 years22,313 (13.5)70,319 (10.4) 55–64 years48,243 (29.1)179,106 (26.4) 65–74 years56,647 (34.2)245,638 (36.2) 75–84 years24,863 (15.0)141,349 (20.8) 85+ years2,069 (1.2)13,913 (2.0)Comorbidities, n (%) AIDS411 (0.2)750 (0.1)<0.001 Alcohol abuse8,201 (5.0)21,615 (3.2)<0.001 Arrhythmia77,432 (46.8)323,550 (47.6)0.001 Deficiency anemia31,266 (18.9)104,534 (15.4)<0.001 Blood loss anemia2,429 (1.5)8,887 (1.3)0.001 Heart failure4,598 (2.8)15,501 (2.3)<0.001 Chronic lung disease49,739 (30.0)138,604 (20.4)<0.001 Coagulopathy15,513 (9.4)62,565 (9.2)0.40 Diabetes mellitus Uncomplicated22,745 (13.7)106,582 (15.7)<0.001 Complicated46,270 (27.9)168,563 (24.8)<0.001 Drug abuse8,283 (5.0)11,507 (1.7)<0.001 Hypertension102,975 (62.2)426,921 (62.9)0.02 Hypothyroidism25,035 (15.1)71,969 (10.6)<0.001 Liver disease6,642 (4.0)17,427 (2.6)<0.001 Lymphoma622 (0.4)2,827 (0.4)0.10 Fluid & electrolyte imbalance68,663 (41.5)253,919 (37.4)<0.001 Metastatic cancer432 (0.3)1,693 (0.2)0.56 Neurological disorders16,317 (9.9)36,912 (5.4)<0.001 Obesity53,047 (32.0)178,652 (26.3)<0.001 Paralysis5,954 (3.6)17,930 (2.6)<0.001 Peripheral vascular disease30,753 (18.6)115,238 (17.0)<0.001 Pulmonary circulation disorders905 (0.5)1,734 (0.3)<0.001 Renal failure29,945 (18.1)125,270 (18.4)0.08 Valvular disease4,264 (2.6)10,746 (1.6)<0.001 Weight loss8,153 (2.6)27,677 (4.1)<0.001Median household income, n (%)<0.001 1st quartile44,960 (27.2)176,910 (26.0) 2nd quartile47,869 (28.9)189,025 (27.8) 3rd quartile41,274 (24.9)172,846 (25.4) 4th quartile29,128 (17.6)130,140 (19.2) Missing2,366 (1.4)10,312 (1.5)Insurance, n (%)<0.001 Medicaid17,035 (10.3)47,619 (7.0) Medicare92,249 (55.7)386,407 (56.9) Other6,298 (3.8)21,343 (3.1) Private45,992 (27.8)208,521 (30.7) Uninsured4,023 (2.4)15,344 (2.3)Surgical urgency, n (%)<0.001 Elective83,485 (50.4)308,031 (45.3) Non-elective81,643 (49.3)369,169 (54.4) Missing469 (0.3)2,033 (0.3)Type of procedure, n (%) CABG only104,552 (63.1)437,217 (64.4)<0.001 Valve only36,762 (22.2)134,675 (19.8)<0.001 Aorta only4,219 (2.5)15,918 (2.3)0.002 Combination of procedures20,064 (12.1)91,423 (13.5)<0.001AIDS, acquired immunodeficiency syndrome; CABG, coronary artery bypass grafting; MHD, mental health disorder. Preoperative patient characteristics and operative details stratified by MHD before propensity score matching AIDS, acquired immunodeficiency syndrome; CABG, coronary artery bypass grafting; MHD, mental health disorder. Table 3Hospital characteristics stratified by MHD status before propensity score matchingVariableMHD (N=165,597)No MHD (N=679,233)P valueLocation/teaching status, n (%)0.18 Rural 26,581 (16.1)110,626 (16.3) Urban nonteaching134,578 (81.2)553,234 (81.4) Urban teaching4,438 (2.7)15,373 (2.3)Urban-rural designation, n (%)<0.001 Large metropolitan areas with ≥1 million residents91,296 (55.1)364,227 (53.6) Small metropolitan areas with ≤1 million residents69,863 (42.2)299,633 (44.1) Micropolitan areas4,106 (2.5)14,734 (2.2) Not metropolitan or micropolitan†331 (0.2)639 (0.1)Bed size, n (%)0.52 Small14,405 (8.7)61,071 (9.0) Medium38,332 (23.1)156,900 (23.1) Large112,860 (68.2)461,263 (67.9)Ownership, n (%)0.92 Government13,087 (7.9)53,613 (7.9) Private, not-profit132,141 (79.8)540,588 (79.6) Private, investor-owned20,369 (12.3)85,033 (12.5)†, non-urban residual. MHD, mental health disorder. Hospital characteristics stratified by MHD status before propensity score matching †, non-urban residual. MHD, mental health disorder. Table 4 shows the complications and mortality outcomes in the propensity score-matched cohorts. Patients with MHD experienced lower inpatient mortality than their counterparts without (2.3% vs. 3.2%), but higher rates of complications (42.1% vs. 39.1%). Both comparisons were significant at P<0.001. Among complications, we note the higher percentage of patients experiencing stroke and delirium (5.6% vs. 4.7%, and 3.3% vs. 1.8%, respectively) as well as blood transfusion and pneumonia (19.2% vs. 17.8%, and 10.5% vs. 9.7%, respectively) in patients with MHD than without. Mean hospital LOS was greater among patients with MHDs than without MHDs (12.0±10.4 vs. 11.0±9.7, P<0.001). Unadjusted comparisons before PSM can be found in Table S2. Table 4Propensity-matched complications and mortality outcomes for patients with or without pre-operative MHDVariableMHD (n=162,638)No MHD (n=157,594)P valueHospital mortality3,688 (2.3)5,034 (3.2)<0.0001Complications Any complication68,515 (42.1)61,660 (39.1)<0.0001 Stroke9,047 (5.6)7,372 (4.7)<0.0001 Ischemic8,649 (5.3)6,989 (4.4)<0.0001 Hemorrhagic794 (0.5)692 (0.4)0.15 Blood transfusion31,233 (19.2)28,071 (17.8)<0.0001 Renal complication2,418 (1.5)2,795 (1.8)<0.0001 Pneumonia17,147 (10.5)15,298 (9.7)<0.0001 Cardiac complications1,927 (1.2)2,102 (1.3)0.02 Cardiac arrest634 (0.4)695 (0.4)0.16 Heart failure1,314 (0.8)1,435 (0.9)0.04 Respiratory failure19,575 (12.0)18,095 (11.5)0.057 PE/DVT2,645 (1.6)2,527 (1.6)0.74 Ileus/GI complications5,334 (3.3)5,334 (3.4)0.31 Non-GI bleeding6,021 (3.7)6,017 (3.8)0.30 Delirium5,370 (3.3)2,900 (1.8)<0.0001 Infection or sepsis5,817 (3.6)5,782 (3.7)0.40Discharge status<0.0001 Home health care67,056 (41.2)65,087 (41.3) Home, routine54,071 (33.2)58,813 (35.5) Other4,248 (2.6)5,332 (3.4) Transfer to SNF36,209 (22.3)27,461 (17.4) Transfer to short facility1,098 (0.7)901 (0.6)Numeric outcomes Length of stay, days12.0±10.4 (9.0)11.0±9.7 (8.0)<0.001Data are presented as mean ± SD (median) or n (%). DVT, deep vein thrombosis; GI, gastrointestinal; MHD, mental health disorder; PE, pulmonary embolism; SD, standard deviation; SNF, skilled nursing facility. Propensity-matched complications and mortality outcomes for patients with or without pre-operative MHD Data are presented as mean ± SD (median) or n (%). DVT, deep vein thrombosis; GI, gastrointestinal; MHD, mental health disorder; PE, pulmonary embolism; SD, standard deviation; SNF, skilled nursing facility. The MHD cohort also had higher readmission rates at 30 and 90 days compared to the non-MHD cohort (14.75% vs. 12.9% and 22.3% vs. 19.5%, respectively, P<0.01 for both comparisons; see Table 5). After multivariable adjustment, patients with MHDs had higher odds of complications [adjusted odds ratio (aOR): 1.16, 95% confidence interval (CI): 1.14–1.19] and higher odds of 30- and 90-day readmissions (aOR: 1.17, 95% CI: 1.14–1.21 and aOR: 1.18, 95% CI: 1.14–1.21, respectively), but lower odds of in-hospital mortality 0.71 (95% CI: 0.67–0.76; Table 6, Figure 1; findings from the full multivariable models before and after PSM can be found in Tables S3-S6). Of note is that the two most common primary diagnoses for both 30- and 90-day readmissions were infection following a procedure and hypertensive heart disease with heart failure, regardless of patients’ MHD status. The list of top 10 primary diagnoses for readmissions is shown in Table 7. A subanalysis of the top 10 primary readmission diagnoses that showed the largest difference between patients with MHDs without MHD is displayed in Table 8. Notably, patients with MHD had higher readmissions for pain-related diagnoses within 30 and 90 days, including chest pain, postcardiotomy syndrome and general uncontrolled pain. Infection was also a more common cause, including infective endocarditis, urinary tract infection (UTI), pneumonia, and surgical site infections. Table 5Readmissions for propensity-matched patients with or without preoperative MHDVariableMHDNo MHDP valueIndex number (weighted) Number145,615139,494 30-day readmission, n (%)21,355 (14.7)17,969 (12.9)<0.001Index number (weighted) Number118,878114,473 90-day readmission, n (%)26,552 (22.3)22,348 (19.5)<0.001MHD, mental health disorder. Readmissions for propensity-matched patients with or without preoperative MHD MHD, mental health disorder. Table 6MHDs before and after PSMMultivariable modelsBefore PSMAfter PSMaOR (95% CI)P valueaOR (95% CI)P valueAny complication1.19 (1.17–1.21)<0.0011.16 (1.14–1.19)<0.001Mortality0.67 (0.63–0.70)<0.0010.71 (0.67–0.76)<0.00130-day readmission1.19 (1.16–1.22)<0.0011.17 (1.14–1.21)<0.00190-day readmission1.20 (1.17–1.23)<0.0011.18 (1.14–1.21)<0.001aOR, adjusted odds ratio; CI, confidence interval; MHD, mental health disorder; PSM, propensity score matching. MHDs before and after PSM aOR, adjusted odds ratio; CI, confidence interval; MHD, mental health disorder; PSM, propensity score matching. Association between MHD and outcomes among propensity-score matched patients undergoing cardiovascular surgery. MHD, mental health disorder. Table 7Top 10 primary diagnoses on 30- and 90-day readmissions for propensity-matched patients with and without MHDRank30-day readmissions90-day readmissionsMHD (n*=24,052 readmissions)No MHD (n*=19,847 readmissions)MHD (n*=36,046 readmissions)No MHD (n*=29,227 readmissions)DiagnosisN (%)DiagnosisN (%)DiagnosisN (%)DiagnosisN (%)1Infection following a procedure1,447 (6.0)Infection following a procedure1,306 (6.6)Infection following a procedure1,938 (5.4)Infection following a procedure1,810 (6.2)2Hypertensive heart with heart failure1,245 (5.2)Hypertensive heart with heart failure989 (5.0)Hypertensive heart with heart failure1,640 (4.5)Hypertensive heart with heart failure1,377 (4.7)3Sepsis943 (3.9)Pleural effusion825 (4.2)Sepsis1,458 (4.0)Sepsis1,136 (3.9)4Pleural effusion881 (3.7)Sepsis748 (3.8)Hypertensive heart and chronic kidney disease1,199 (3.3)Hypertensive heart and chronic kidney disease1,073 (3.7)5Hypertensive heart and chronic kidney disease795 (2.3)Hypertensive heart and chronic kidney disease774 (3.9)Pleural effusion1,044 (2.9)Pleural effusion1,023 (3.5)6Paroxysmal atrial fibrillation554 (2.3)Paroxysmal atrial fibrillation540 (2.7)Pneumonia787 (2.2)Non-ST elevation myocardial infarction634 (2.2)7Pneumonia541 (2.3)Pulmonary embolism459 (2.2)Non-ST elevation myocardial infarction728 (1.9)Paroxysmal atrial fibrillation571 (1.9)8Pulmonary embolism552 (2.0)Unspecified atrial fibrillation426 (2.0)Paroxysmal atrial fibrillation678 (1.6)Pneumonia534 (1.8)9Pericardial effusion486 (1.8)Pneumonia403 (2.0)Pulmonary embolism628 (1.6)Acute on chronic systolic heart failure533 (1.8)10Acute kidney failure443 (1.6)Pericardial effusion390 (1.8)Chest pain596 (1.7)Acute kidney failure531 (1.8)*, weighted. MHD, mental health disorder. Top 10 primary diagnoses on 30- and 90-day readmissions for propensity-matched patients with and without MHD *, weighted. MHD, mental health disorder. Table 8Diagnosis percentage differences on 30- and 90-day readmissions for propensity-matched patients with or without MHDMHD vs. no MHDPercentage difference30-day readmissions Chest pain0.36 Postpericardiotomy syndrome0.29 Infective endocarditis0.26 UTI0.25 Postprocedural pain0.25 Hypertension with HF0.24 Orthostatism0.15 COPD exacerbation0.14 Pneumonia0.12 Incisional SSI0.11 Dehydration0.1090-day readmissions Chest pain0.36 Pneumonia0.36 Chest pain0.27 UTI0.18 PE0.18 Postprocedural pain0.18 Infective endocarditis0.16 Postpericardiotomy syndrome0.16 Orthostatism0.14 Noninfective gastroenterocolitis0.14 CHF0.12CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; HF, heart failure; MHD, mental health disorder; PE, pulmonary embolism; SSI, surgical site infection; UTI, urinary tract infection. Diagnosis percentage differences on 30- and 90-day readmissions for propensity-matched patients with or without MHD CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; HF, heart failure; MHD, mental health disorder; PE, pulmonary embolism; SSI, surgical site infection; UTI, urinary tract infection. Discussion This is one of the largest studies aimed at assessing the association between MHDs and surgical outcomes (7-9). Among patients with MHDs who underwent cardiac surgery, we found that more patients with MHDs than without experienced complications and readmissions within 30 to 90 days post-discharge. These findings emphasize the significance of including MHDs of patients undergoing cardiac surgery as part of risk stratification scores for Society of Thoracic Surgeons (STS) and European System for Cardiac Operative Risk Evaluation (EuroSCORE) (4-6). Interestingly, in contrast to other cohorts, this study found that mortality was lower in patients with MHDs, yet the prevalence of complications was higher (7,8). One explanation may be selection bias, such that patients with MHD undergoing surgery are among the healthier and/or least disadvantaged individuals with MHD. Indeed, as shown in Table 1, the prevalence of mood (affective) disorders and psychotic disorders was much lower among patients who underwent cardiovascular procedures than in the inpatient population who did not undergo such procedures. Although we used PSM, we could only perform matching on variables that are available in the database. Several other factors, including (but not limited to) better adherence to medications, greater awareness of symptoms, better access to care, social support, and advocacy—whether self-advocacy or by others—could not be accounted for in our analysis. The increased prevalence of stroke and delirium in patients with MHDs deserves specific attention and warrants further investigation. One possible explanation is that MHDs may be exacerbating the stress response or inflammatory reaction to surgery via cytokine release, including interleukin (IL)-1β, IL-6, IL-12, and IL-18 with interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α), leading to an increased risk of these complications (13). This inflammation, associated with oxidative stress, may be one of the underlying causes of the significant increase in delirium among patients with MHDs seen in this statistical analysis, though this is purely hypothetical and requires further study to confirm in the clinical setting (14). Such inflammatory responses in the context of MHDs have also been the focus of many enhanced recovery after surgery (ERAS) protocols, including the ERAS Cardiac Society (15,16). Mitigation of this risk includes postoperative systematic delirium screening using the Confusion Assessment Method for the Intensive Care Unit or the Intensive Care Unit Delirium Screening Checklist (17). ERAS protocols may also serve to better manage postoperative pain in this patient population—we found that readmissions are more commonly associated with this diagnosis. ERAS protocols also emphasize the importance of perioperative optimization of mental health status in optimizing postoperative outcomes by integrating preoperative cognitive interventions to decrease delirium after cardiac surgery. These include psychosocial education about what to expect regarding steps in care and pain management to allay anxiety, stress management and relaxation techniques such as guided imagery, medication, and deep breathing exercises, cognitive behavioral interventions, and structured counseling and support. Evidence-based care that aligns with recommendations from the ERAS Cardiac Society and collaborating with mental health providers can decrease this complication, particularly in this vulnerable patient population. Many cardiac surgery patients may still not be adequately followed by mental health professionals, making complications like delirium less likely to be recognized and consequently worsen postoperative outcomes (18). We propose that it may be a worthwhile opportunity for improvement. In our cohort, just over 50% of patients with MHD presented for an urgent indication rather than an elective. A number of these patients were readmitted with indication of infective endocarditis (more so than those without MHD), raising the possibility that many of these patients may have suffered from concomitant intravenous substance use. In this setting, extensive pre-operative optimization would likely not be possible. However, this would not hinder postoperative establishment of care with mental health practitioners, early intensive care unit (ICU) delirium screening, and many of the same interventions mentioned above that are currently part of preoperative prehabilitation protocols. The increased odds of readmission at 30 and 90 days in patients with MHDs may suggest that this population faces challenges with short-term postoperative follow-up care coordination with their health professionals (19). This finding not only supports the need for risk assessment before surgery, but also the need for more robust post-discharge support and follow-up with the healthcare team, including mental health. These national data imply that clinical risk prediction and preoperative screening should routinely include MHDs. Mental health services may be involved in perioperative care to reduce complications and prevent readmissions so patients can benefit from targeted treatments aimed at optimizing cardiac surgery outcomes. This study also paves the way for future important analyses focusing on the specific psychiatric conditions to determine whether—within the MHD group—certain diagnoses (e.g., psychotic disorders) are associated with worse outcomes than others, further enhancing our ability to risk-stratify patients with MHDs. Study limitations First, our study has all the limitations associated with the use of administrative data, such as the potential for miscoding, over- or under-coding, and the lack of clinical granularity, such as intraoperative data (e.g., cardiopulmonary bypass time, cross-clamp time, surgeon or center volume) and cause of death, afforded by other databases. Additionally, the NRD captures only in-hospital mortality and complications occurring during a given stay, and readmissions for patients crossing state borders may not be captured. Second, some of the comorbidities included in the Elixhauser Comorbidity Index may be reflective of postoperative complications. These data may also underrepresent the real number of patients with MHDs due to the underdiagnosis or under-coding of these conditions (20). Lastly, we note that while this study evaluates the association between a group of MHDs and cardiovascular surgery outcomes, we acknowledge the heterogeneity of the patient population identified in the broad MHD cohort. It should be noted that even within MHD subtypes there is a wide spectrum of disease severity and type and therefore effect on outcomes. Therefore, future studies should evaluate the granular association between specific MHDs and postoperative outcomes. Despite these limitations, the NRD offers a well-powered analysis of a real-world cohort of patients undergoing cardiac surgery that has not been studied to date in this surgical discipline yet. It is important that future studies validate the findings of this work to further evaluate subsets of this population and define ideal screening and intervention protocols. Conclusions Mental health professionals may be involved in optimizing psychiatric conditions to improve in-hospital complications in this vulnerable population. Integration of mental health services in the postoperative care of these patients may also help improve readmissions. Surgeons may not limit access to surgical treatment due to MHDs. Supplementary The article’s supplementary files as Acknowledgments We would like to thank Tess Parry for her help with editing the manuscript and Brian Kohlbacher for his help with editing the Figure. Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Footnotes Reporting Checklist: The authors have completed the STROBE reporting checklist. Available at https://jtd.amegroups.com/article/view/10.21037/jtd-2025-aw-2208/rc Funding: This work was supported internally by the Cleveland Clinic Department of Thoracic and Cardiovascular Surgery. Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2025-aw-2208/coif). The authors have no conflicts of interest to declare. References Available at https://jtd.amegroups.com/article/view/10.21037/jtd-2025-aw-2208/prf Supplementary Materials The article’s supplementary files as